Second major acquisition sets Singapore headquartered company on course to uniquely drive global therapeutic innovation from Asia. AUM Biosciences (AUM), an award-winning company focused on the...
Opening of the continuous manufacturing facilities and expansion of production building will boost capabilities to accelerate the supply of new breakthrough medicines to patients globally. As part of...
Only account for 10 per cent of total revenue for public hospitals funds. Chinese government subsidies to public hospitals have increased by 15.6 per cent annually since 2010, a health official said...
